The findings, presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and published simultaneously in JCO Oncology Practice, suggest those taking GLP-1 medications had approximately 30% lower odds of developing breast cancer compared with non-users
Shortages of Wegovy, driven by supply-chain interruptions, have kept demand limited since it won approval in June 2021
Methods Using a subset of Truveta Data, we identified adults who were prescribed a GLP-1 RA medication between January 01, 2024 and July 31, 2025
Understanding Semaglutide Semaglutide, an FDA-approved GLP-1 receptor agonist, is specifically designed for chronic weight management in adults
Expect meaningful improvement within 2 to 3 weeks with quality BPC-157 and appropriate protocol adherence
However, as many people look for ways to increase their levels, the question often shifts from why we need it to how we should take it